Keiko Matano

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

Masanori Isaka, Yoko Yasuda, Masashi Mizokami et al. · Vaccine · 2001 · 77 citations

Vaccination, Intranasal Co-administration, Mucosal Vaccination +10

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

Kunio Tochikubo, Masanori Isaka, Yoko Yasuda et al. · Vaccine · 1998 · 76 citations

Microbial Toxin, Mucosal Vaccination, Mucosal Immunology +6

Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant

Masanori Isaka, Yoko Yasuda, Satoshi Kozuka et al. · Vaccine · 1999 · 50 citations

Vaccination, Mucosal Vaccination, Medicine +8

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

Norihisa Goto, Jun‐ichi Maeyama, Yoko Yasuda et al. · Vaccine · 2000 · 45 citations

Microbial Toxin, Virulence Factor, Pathogenesis +9

Affinity purification of recombinant cholera toxin B subunit oligomer expressed in<i>Bacillus brevis</i>for potential human use as a mucosal adjuvant

Yoko Yasuda, Keiko Matano, Toru Asai et al. · FEMS Immunology & Medical Microbiology · 1998 · 31 citations

Toxinology, Bacteriology, Glycobiology +17